NIH-funded research R01 grant

Improving access to HIV and hepatitis C testing for people who inject drugs.

Official title: Project ACCESS: Advancing Equitable Access to HIV/HCV Testing Through Structural Transformation in Syringe Services Programs: A Cluster Randomized Trial

Funded at University of Miami School of Medicine · NIH-11124059 · Data updated 2026-11-12

This study is looking to make it easier for people who inject drugs to get tested for HIV and hepatitis C by improving syringe services programs, so if you’re part of this community, you might find it easier to access testing and get the support you need for better health.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Miami School of Medicine
NIH-funded
Lab location1 site (Coral Gables, United States)
Project startJuly 1, 2024
Project endApril 30, 2029
Funding year2025
Award (this year)$661,225
NIH project number5R01DA060462-02
Project IDNIH-11124059 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals who inject drugs and are at risk for HIV and hepatitis C infections.

Less likely to help

Patients who do not inject drugs or are not at risk for HIV or hepatitis C may not benefit from this research.

What this research studies

This research aims to enhance the availability and uptake of HIV and hepatitis C testing among people who inject drugs (PWID) by transforming syringe services programs (SSPs). It will implement a comprehensive strategy that addresses organizational barriers to testing, such as financial constraints and staff training. By conducting a cluster randomized trial, the project will evaluate the effectiveness of these interventions in increasing testing rates and improving health outcomes for PWID. Participants will be engaged in community health settings to ensure that testing is accessible and effective.

Why it matters

Potential benefit: If successful, this research could significantly increase the number of people who know their HIV and hepatitis C status, leading to timely treatment and better health outcomes.

How similar studies have gone: Previous research has shown success in implementing similar strategies to improve testing rates in community health settings, indicating a promising approach.

Where this research is happening

  • University of Miami School of Medicine
    Coral Gables, United States
    Active

Researchers

  • Principal investigator: Bartholomew, Tyler Scott — University of Miami School of Medicine
  • Study coordinator: Bartholomew, Tyler Scott

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.